DREAM Complex Maintenance of Human Beta Cell Quiescence
DREAM 复合物维持人类 β 细胞静止
基本信息
- 批准号:10267388
- 负责人:
- 金额:$ 61.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAffectAgonistAmericanBeta CellCCNE1 geneCDC2 geneCDKN1A geneCDKN1C geneCREBBP geneCalciumCalcium ChannelCell CountCell CycleCell Cycle RegulationCell Differentiation processCell NucleusCell ProliferationChromatinChromatin Structure AlterationComplexCyclic AMPCyclic AMP-Dependent Protein KinasesCyclin ACyclinsDiabetes MellitusDimethyl SulfoxideDoseDrug CombinationsEZH2 geneEnzyme Inhibitor DrugsExtended FamilyFK506FOXM1 geneFamilyGCG geneGene ProteinsGenesGenomeGoalsHarmineHumanIn VitroInsulinInsulin-Dependent Diabetes MellitusLabelLinkMaintenanceMediatingMediator of activation proteinMetabolic syndromeModelingNatural regenerationNon-Insulin-Dependent Diabetes MellitusNuclearPathway interactionsPharmaceutical PreparationsPhosphotransferasesPolycombPrediabetes syndromeRefractoryRegulationResearchResidual stateRoleScaffolding ProteinSignal TransductionStructure of beta Cell of isletTransforming Growth Factor betaYY1 Transcription Factoranalogc-myc Genescell regenerationgenome-wideglobal healthin vivoindexinginhibitor/antagonistinsulinomaisletmembernovelnovel strategiesreceptorregenerative therapytherapeutic targettraffickingtranscription factor
项目摘要
Summary
Types 1 and 2 diabetes result entirely or in part from a reduction in numbers of normally functioning pancreatic
beta cells. Residual beta cells are present in most people with diabetes, suggesting that regenerative therapies
may be uniquely helpful. Inducing human beta cells to regenerate has proven impossible until recently. This
has changed with the discovery by several labs of drugs that inhibit the kinase, DYRK1A, and which induce
human beta cells to replicate at “rates”, or more properly, “labeling indices”, of ~2%. Proliferation can be
augmented by combining DYRK1A inhibitors with TGF-beta superfamily inhibitors or with GLP1 receptor
agonists, generating labeling indices of 5-8%. Although these are exciting advances, they also demonstrate
that >90% of human beta cells are recalcitrant to cell cycle entry. The cause of this remarkable refractoriness
to proliferation is poorly understood.
DYRK1A inhibition alters intracellular trafficking of the NFaT family of transcription factors. In the course of our
studies on human insulinomas, we have uncovered a parallel pathway, the DREAM-MMB complex, that also
restricts human beta cell proliferation. We show here that the extended family of ~200 canonical DREAM-MMB
complex genes and proteins appear to be present in human beta cells, and that DREAM complex is switched
from a repressive to a proliferative configuration by DYRK1A inhibition. In addition, we have also observed
potential overlapping roles for Trithorax and Polycomb complexes with the DREAM complex in restraining
human beta cell proliferation. Accordingly, in this application, we propose three Specific Aims:
Aim 1. Complete The Characterization of the Functional DREAM-MMB Complex in the Human Beta Cell.
Aim 2. Delineate Candidate DREAM-MMB Complex Target Genes in the Human Beta Cell.
Aim 3. Aim 3. Define Genome-Wide Integration of Repressive and Proliferative DREAM-MMB Mediators
with Trithorax and Polycomb Chromatin Regulators and DREAM Target Genes in Human Beta Cells.
Our overarching goals are: 1) to clearly and comprehensively define the fundamental mechanisms that enforce
quiescence in the adult human beta cell; 2) to more clearly elucidate the fundamental mechanisms through
which DYRK1A inhibitors, TGFβ inhibitors and GLP1RA’s synergize to induce their remarkable rates of human
beta cell proliferation; and 3) to reveal novel pathways and further expand therapeutic targets for human beta
cell regeneration for diabetes.
摘要
1型和2型糖尿病的全部或部分原因是正常胰腺功能的数量减少。
β细胞。在大多数糖尿病患者中都存在残留的β细胞,这表明再生疗法
可能会有独一无二的帮助。直到最近,诱导人β细胞再生一直被证明是不可能的。这
随着几个实验室发现了抑制激酶DYRK1A的药物,并诱导
人类β细胞以~2%的“速率”复制,或者更确切地说,是“标记指数”。扩散可以是
通过将DYRK1A抑制剂与转化生长因子-β超家族抑制剂或与GLP1受体结合而增强
激动剂,产生5-8%的标记指数。尽管这些都是令人兴奋的进步,但它们也证明了
90%的人类β细胞不能进入细胞周期。这一惊人的不可抗拒的原因
对核扩散的了解甚少。
抑制DYRK1A改变NFAT转录因子家族的细胞内运输。在我们的过程中
在对人类胰岛素瘤的研究中,我们发现了一条平行的途径,即梦想-MMB复合体,这也是
限制人类β细胞的增殖。我们在这里展示了~200个经典梦想-MMB的大家庭
人类β细胞中似乎存在复杂的基因和蛋白质,而梦境复合体发生了转换
通过抑制DYRK1A,从抑制性构型转变为增殖性构型。此外,我们还观察到
三胸和多梳复合体与梦境复合体在抑制中的潜在重叠作用
人类β细胞的增殖。因此,在本申请中,我们提出了三个具体目标:
目的1.完成人Beta细胞中功能性DREAM-MMB复合体的鉴定。
目的2.在人Beta细胞中筛选DREAM-MMB复合靶基因。
目标3.目标3.定义抑制性和增殖性梦境-MMB介体的全基因组整合
在人类Beta细胞中使用三胸和多梳染色质调节剂和梦想靶基因。
我们的总体目标是:1)明确和全面地界定执行
成人β细胞中的静息;2)更清楚地阐明通过
DYRK1a抑制剂、转化生长因子β抑制剂和GLP1RA的协同作用诱导其对人
β细胞增殖;以及3)揭示人类β细胞的新途径和进一步扩大治疗靶点
糖尿病的细胞再生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW F. STEWART其他文献
ANDREW F. STEWART的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW F. STEWART', 18)}}的其他基金
DREAM Complex Maintenance of Human Beta Cell Quiescence
DREAM 复合物维持人类 β 细胞静止
- 批准号:
10427406 - 财政年份:2021
- 资助金额:
$ 61.53万 - 项目类别:
DREAM Complex Maintenance of Human Beta Cell Quiescence
DREAM 复合物维持人类 β 细胞静止
- 批准号:
10619645 - 财政年份:2021
- 资助金额:
$ 61.53万 - 项目类别:
Pancreatic Islet Growth Factors: Transgenic and Viral Modeling
胰岛生长因子:转基因和病毒模型
- 批准号:
8815293 - 财政年份:2012
- 资助金额:
$ 61.53万 - 项目类别:
Pancreatic Islet Growth Factors: Transgenic and Viral Modeling
胰岛生长因子:转基因和病毒模型
- 批准号:
8636445 - 财政年份:2012
- 资助金额:
$ 61.53万 - 项目类别:
Pancreatic Islet Growth Factors: Transgenic and Viral Modeling
胰岛生长因子:转基因和病毒模型
- 批准号:
8583716 - 财政年份:2012
- 资助金额:
$ 61.53万 - 项目类别:
Pancreatic Islet Growth Factors: Transgenic and Viral Modeling
胰岛生长因子:转基因和病毒模型
- 批准号:
8470622 - 财政年份:2012
- 资助金额:
$ 61.53万 - 项目类别:
Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell Replication
驱动治疗性人类β细胞复制的多学科方法
- 批准号:
8144434 - 财政年份:2010
- 资助金额:
$ 61.53万 - 项目类别:
Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell Replication
驱动治疗性人类β细胞复制的多学科方法
- 批准号:
8636565 - 财政年份:2010
- 资助金额:
$ 61.53万 - 项目类别:
Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell Replication
驱动治疗性人类β细胞复制的多学科方法
- 批准号:
8717646 - 财政年份:2010
- 资助金额:
$ 61.53万 - 项目类别:
Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell Replication
驱动治疗性人类β细胞复制的多学科方法
- 批准号:
8316307 - 财政年份:2010
- 资助金额:
$ 61.53万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 61.53万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 61.53万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 61.53万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 61.53万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 61.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 61.53万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 61.53万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 61.53万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 61.53万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 61.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists